Similarities in the metabolism of alloxan and dehydroascorbate in human erythrocytes

Biochemical Pharmacology

Volumn 55, Issue 8, 1998, Pages 1301-1307

  Davis Jr , John L ^a   Mendiratta, Shalu ^a   May, James M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alloxan; Ascorbate; Dehydroascorbate; Dialuric acid; Human erythrocytes; tocopherol

Indexed keywords

ALLOXAN; ALPHA TOCOPHEROL; AMINOTRIAZOLE; ASCORBIC ACID; CATALASE; DEHYDROASCORBIC ACID; DIALURIC ACID; FERRICYANIDE; HYDROGEN PEROXIDE; NINHYDRIN;

ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG METABOLISM; DRUG STABILITY; DRUG UPTAKE; ERYTHROCYTE DISORDER; HEXOSE MONOPHOSPHATE SHUNT; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0032523106     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00637-0     Document Type: Article

References (43)

1. Vera JC, Rivas CI, Fischbarg J, Golde DW. Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature. 364:1993;79-82.
2. May JM, Qu Z-C, Whitesell RR. Ascorbic acid recycling enhances the antioxidant reserve of human erythrocytes. Biochemistry. 34:1995;12721-12728.
3. Gorus FK, Malaisse WJ, Pipeleers DG. Selective uptake of alloxan by pancreatic B-cells. Biochem J. 208:1982;513-515.
4. Weaver DC, McDaniel ML, Naber SP, Barry CD, Lacy PE. Alloxan stimulation and inhibition of insulin release from isolated rat islets of Langerhans. Diabetes. 27:1978;1205-1214.
5. Patterson JW, Lazarow A. Reactions of alloxan and dialuric acid with the sulfhydryl group. J Biol Chem. 177:1949;197-204.
6. Basu S, Som S, Deb S, Mukherjee D, Chatterjee IB. Dehydroascorbic acid reduction in human erythrocytes. Biochem Biophys Res Commun. 90:1979;1335-1340.
7. May JM, Qu ZC, Whitesell RR, Cobb CE. Ascorbate recycling in human erythrocytes Role of GSH in reducing dehydroascorbate . Free Radic Biol Med. 20:1996;543-551.
8. Munday R. Dialuric acid autoxidation. Effects of transition metals on the reaction rate and on the generation of "active oxygen" species. Biochem Pharmacol. 37:1988;409-413.
9. Khan MM, Martell AE. Metal ion and metal chelate catalyzed oxidation of ascorbic acid by molecular oxygen. I. Cupric and ferric ion catalyzed oxidation. J Am Chem Soc. 89:1967;4176-4185.
10. Buettner GR, Jurkiewicz BA. Catalytic metals, ascorbate and free radicals Combinations to avoid . Radiat Res. 145:1996;532-541.
11. Malaisse WJ. Alloxan toxicity to the pancreatic B-cell. A new hypothesis. Biochem Pharmacol. 31:1982;3527-3534.
12. ·formation. Biochem Pharmacol. 38:1989;271-277.
13. Orringer EP, Roer ME. An ascorbate-mediated transmembrane-reducing system of the human erythrocyte. J Clin Invest. 63:1979;53-58.
14. Grebing C, Crane FL, Löw H, Hall K. A transmembranous NADH-dehydrogenase in human erythrocyte membranes. J Bioenerg Biomembr. 16:1984;517-533.
15. May JM, Qu Z-C, Whitesell RR. Ascorbate is the major electron donor for a transmembrane oxidoreductase of human erythrocytes. Biochim Biophys Acta. 1238:1995;127-136.
16. May JM, Qu ZC, Morrow JD. Interaction of ascorbate and α-tocopherol in resealed human erythrocyte ghosts. Transmembrane electron transfer and protection from lipid peroxidation. J Biol Chem. 271:1996;10577-10582.
17. Iheanacho EN, Hunt NH, Stocker R. Vitamin C redox reactions in blood of normal and malaria-infected mice studied with isoascorbate as a nonisotopic marker. Free Radic Biol Med. 18:1995;543-552.
18. Bui-Nguyên MH. Application of high-performance liquid chromatography to the separation of ascorbic acid from isoascorbic acid. J Chromatogr. 196:1980;163-165.
19. van Hemmen JJ, Meuling WJ. Inactivation of Escherichia coli by superoxide radicals and their dismutation products. Arch Biochem Biophys. 182:1977;743-748.
20. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem. 74:1976;214-226.
21. Lang JK, Gohil K, Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem. 157:1986;106-116.
22. Takeda H, Shibuya T, Yanagawa K, Kanoh H, Takasaki M. Simultaneous determination of α-tocopherol and α-tocopherolquinone by high-performance liquid chromatography and coulometric detection in the redox mode. J Chromatogr A. 722:1996;287-294.
23. Tephly TR, Mannering GJ, Parks RE Jr. Studies on the mechanism of inhibition of liver and erythrocyte catalase activity by 3-amino-1,2,4-triazole (AT). J Pharmacol Exp Ther. 134:1961;77-82.
24. 2 production) by ascorbic acid and glucose in the presence of aminotriazole Role of transition metals and relevance to diabetes . Biochem J. 303:1994;935-940.
25. Wolff SP. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol. 233:1994;182-189.
26. Avron M, Shavit N. A sensitive and simple method for determination of ferrocyanide. Anal Biochem. 6:1963;549-554.
27. Steck TL, Kant JA. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol. 31:1974;172-180.
28. εB29-(+)-Biotinylinsulin and its complexes with avidin. Synthesis and biological activity. J Biol Chem. 253:1978;686-690.
29. Miwa I, Okuda J. Non-enzymatic reduction of alloxan by reduced nicotinamide nucleotide. Biochem Pharmacol. 31:1982;921-925.
30. Holmgren A, Lyckeborg C. Enzymatic reduction of alloxan by thioredoxin and NADPH-thioredoxin reductase. Proc Natl Acad Sci USA. 77:1980;5149-5152.
31. Grankvist K, Holmgren A, Luthman M, Täljedal I-B. Thioredoxin and thioredoxin reductase in pancreatic islets may participate in diabetogenic free-radical production. Biochem Biophys Res Commun. 107:1982;1412-1418.
32. Holmgren A, Luthman M. Tissue distribution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. Biochemistry. 17:1978;4071-4077.
33. Nikolaeva MI, Parkhimovich RM, Zaraiskii AV. Alloxan cytotoxicity A new aspect of the problem . Probl Endokrinol (Mosk). 32:1986;75-80.
34. Cohen G, Hochstein P. Glutathione peroxidase The primary agent for the elimination of hydrogen peroxide in erythrocytes . Biochemistry. 2:1963;1420-1428.
35. Reglinski J, Hoey S, Smith WE, Sturrock RD. Cellular response to oxidative stress at sulfhydryl group receptor sites on the erythrocyte membrane. J Biol Chem. 263:1988;12360-12366.
36. Hartman PE. Ergothioneine as antioxidant. Methods Enzymol. 186:1990;310-318.
37. Weaver DC, McDaniel ML, Lacy PE. Alloxan uptake by isolated rat islets of Langerhans. Endocrinology. 102:1978;1847-1855.
38. Hammarström L, Ullberg S. Specific uptake of labelled alloxan in the pancreatic islets. Nature. 212:1966;708-709.
39. Brückmann G, Wertheimer E. Alloxan studies The action of alloxan homologues and related compounds . J Biol Chem. 168:1947;241-256.
40. Leech RS, Bailey CC. Blood alloxan and blood glutathione in rabbits injected with alloxan. J Biol Chem. 157:1945;525-542.
41. Crane FL, Löw H and Clark MG, Plasma membrane redox enzymes. In: The Enzymes of Biological Membranes (Ed. Martonosi AN), 2nd Edn, pp. 465-510. Plenum Press, New York, 1985.
42. Schipfer W, Neophytou B, Trobisch R, Groiss O, Goldenberg H. Reduction of extracellular potassium ferricyanide by transmembrane NADH (acceptor) oxidoreductase of human erythrocytes . Int J Biochem. 17:1985;819-823.
43. Löw H, Crane FL. Hormone regulated redox function in plasma membranes. FEBS Lett. 68:1976;157-159.